We fight to improve the lives
of everyone affected by epilepsy

Stories about cannabis-based medicine

Specialist clinicians in the UK can prescribe cannabis-based medicines to people with “exceptional clinical need”

1 Nov 2018

From today, specialist clinicians can prescribe cannabis-based medicines in the UK to patients with “exceptional clinical need”. They will no longer need to apply to an expert panel for a licence.

The UK government has rescheduled cannabis-based medicines under the Misuse of Drugs regulations 2001. They are now no longer listed under Schedule 1 alongside substances considered to have no therapeutic effect. 

Epilepsy Action update on cannabis-based medicines in the UK

10 Oct 2018

Epilepsy Action senior policy and campaigns officer Sam Mountney provides an update on the current situation with cannabis-based medicines in the UK

"Medicinal cannabis is never far away from the news at the moment. We said we’d follow this issue closely on behalf of the epilepsy community so here’s our take on what’s happened so far and what is happening next.

Trial finds cannabidiol may successfully reduce number of convulsive seizures in children and young adults with Dravet syndrome

25 May 2017

A new study has found that cannabidiol could be an effective treatment for people with Dravet syndrome.

Cannabidiol comes from the cannabis plant. It does not contain the part of cannabis that gives a ‘high’ – the psychoactive part.

Subscribe to cannabis-based medicine